Q1 EPS Estimate for Merit Medical Systems Boosted by Analyst

Merit Medical Systems, Inc. (NASDAQ:MMSIFree Report) – Analysts at Zacks Research boosted their Q1 2027 earnings per share (EPS) estimates for Merit Medical Systems in a note issued to investors on Thursday, August 20th. Zacks Research analyst Team now expects that the medical instruments supplier will post earnings per share of $0.88 for the quarter, up from their prior forecast of $0.84. The consensus estimate for Merit Medical Systems’ current full-year earnings is $3.81 per share. Zacks Research also issued estimates for Merit Medical Systems’ Q4 2027 earnings at $1.10 EPS.

Merit Medical Systems (NASDAQ:MMSIGet Free Report) last posted its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.23. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The company had revenue of $418.84 million for the quarter, compared to the consensus estimate of $405.25 million. During the same period in the previous year, the business earned $1.01 earnings per share. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS.

A number of other research analysts also recently commented on the company. Wells Fargo & Company increased their target price on Merit Medical Systems from $74.00 to $83.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. BTIG Research restated a “buy” rating and issued a $105.00 price target on shares of Merit Medical Systems in a research report on Tuesday, August 11th. Canaccord Genuity Group upped their price target on shares of Merit Medical Systems from $85.00 to $94.00 and gave the company a “buy” rating in a research note on Friday, July 31st. JPMorgan Chase & Co. increased their price objective on shares of Merit Medical Systems from $77.00 to $95.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. Finally, Robert W. Baird set a $98.00 price objective on shares of Merit Medical Systems in a research note on Friday, July 31st. Eight equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $100.00.

Check Out Our Latest Analysis on MMSI

Merit Medical Systems Stock Performance

NASDAQ:MMSI opened at $90.28 on Monday. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. Merit Medical Systems has a 1 year low of $59.74 and a 1 year high of $94.75. The stock’s 50 day simple moving average is $77.88 and its two-hundred day simple moving average is $72.58. The company has a market cap of $5.39 billion, a price-to-earnings ratio of 37.31, a PEG ratio of 2.28 and a beta of 0.48.

Institutional Trading of Merit Medical Systems

A number of institutional investors have recently bought and sold shares of the stock. Bessemer Group Inc. raised its stake in shares of Merit Medical Systems by 54.2% in the fourth quarter. Bessemer Group Inc. now owns 313,981 shares of the medical instruments supplier’s stock valued at $27,674,000 after acquiring an additional 110,392 shares during the period. WINTON GROUP Ltd purchased a new position in shares of Merit Medical Systems during the 4th quarter worth about $12,239,000. Trillium Asset Management LLC purchased a new stake in Merit Medical Systems in the 2nd quarter worth about $6,105,000. Norges Bank purchased a new position in shares of Merit Medical Systems during the fourth quarter valued at approximately $75,957,000. Finally, Quantinno Capital Management LP raised its holdings in shares of Merit Medical Systems by 200.3% in the first quarter. Quantinno Capital Management LP now owns 17,612 shares of the medical instruments supplier’s stock worth $1,214,000 after buying an additional 11,747 shares during the period. 99.66% of the stock is currently owned by institutional investors.

About Merit Medical Systems

(Get Free Report)

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

Featured Stories

Earnings History and Estimates for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.